ADPO: automatic-differentiation-assisted parametric optimization Publication ADPO: automatic-differentiation-assisted parametric optimization See how Automatic differentiation reduces PK/PD model runtime by up to 95% while preserving accuracy,…CertaraSeptember 22, 2025
Best practices in clinical pharmacology gap analysis Blog Best practices in clinical pharmacology gap analysis September 19, 2025 Submitting your New Drug Application (NDA) to the FDA is the ultimate…CertaraSeptember 19, 2025
Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Guide Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…CertaraSeptember 11, 2025
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) CertaraSeptember 4, 2025
Comparing the Altis RepliGut Organoid System to MDCK Monolayers in Predicting the Oral Absorption of Lenalidomide Publication Comparing the Altis RepliGut Organoid System to MDCK Monolayers in Predicting the Oral Absorption of Lenalidomide Learn how organoid systems showed higher permeability and better alignment with in vivo lenalidomide bioavailability,…CertaraAugust 30, 2025
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) On-Demand Webinar Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…CertaraAugust 29, 2025
Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers Publication Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers Find out how palbociclib formulations are bioequivalent under fasting and fed conditions using Phoenix WinNonlinCertaraAugust 18, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Publication Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…CertaraAugust 13, 2025